UniQure sale of 2,645 shares under 10b5-1 plan

UniQure N.V. reported a sale of 2,645 ordinary shares on 06/10/2026 via a stock options exercise and sale pursuant to a 10b5-1 plan.

Rhea-AI Filing Summary

UniQure N.V. reported a sale of 2,645 ordinary shares on 06/10/2026 via a stock options exercise and sale pursuant to a 10b5-1 plan. The filing also lists vested share items of 3,127 shares (vested 02/27/2020) and 1,780 shares (vested 02/25/2021), described as compensation-related. The excerpt identifies the broker as Citigroup Global Markets, Inc. and indicates transactions on NASDAQ.

Insights

Corporate Governance Specialist

Insider sales executed under a 10b5-1 plan; routine compensation vesting also recorded.

The filing shows a stock option exercise and sale pursuant to a 10b5-1 plan for 2,645 ordinary shares on 06/10/2026, routed through Citigroup Global Markets, Inc.. Two additional vested compensation items of 3,127 and 1,780 shares are listed with their respective vesting dates.

These entries are procedural disclosures of insider transactions and vested awards; cashflow treatment and buyer counterparty details are not provided in the excerpt. Subsequent filings may disclose net proceeds or additional transaction details.

Key Figures

Shares sold (exercise+sale): 2,645 shares Vested shares (02/27/2020): 3,127 shares Vested shares (02/25/2021): 1,780 shares +1 more

4 metrics

Shares sold (exercise+sale) 2,645 shares Stock options exercise and sale pursuant to 10b5-1 plan on 06/10/2026

Vested shares (02/27/2020) 3,127 shares Vested shares pursuant to 10b5-1 plan, dated 02/27/2020

Vested shares (02/25/2021) 1,780 shares Compensation-related vested shares dated 02/25/2021

Broker Citigroup Global Markets, Inc. Broker listed for the securities to be sold

Key Terms

10b5-1 plan, Vested Shares, Stock Options Exercise

3 terms

10b5-1 plan regulatory

"Stock Options Exercise and Sale pursuant to 10B5-1 Plan"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Vested Shares financial

"Vested Shares Pursuant to 10b5-1 plan"

Stock Options Exercise financial

"Stock Options Exercise and Sale pursuant to 10B5-1 Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did UniQure (QURE) report in this Form 144?

UniQure reported a sale of 2,645 ordinary shares on 06/10/2026 via a stock options exercise and sale pursuant to a 10b5-1 plan. The filing lists broker details and related vested-share entries with vesting dates.

Who executed the brokered transaction for QURE's Form 144?

The filing names Citigroup Global Markets, Inc. as the broker. It records transactions on NASDAQ and ties the sale to a 10b5-1 plan executed on the stated date.

What vested-share amounts are disclosed for UniQure in this excerpt?

The excerpt lists vested-share items of 3,127 shares with vesting date 02/27/2020 and 1,780 shares with vesting date 02/25/2021, described as compensation-related vesting.

Does the Form 144 excerpt state the cash proceeds received by UniQure?

The excerpt does not state net cash proceeds or sale prices. It documents the exercise and sale method and share counts but does not disclose proceeds or per-share sale prices.

Was the sale executed under a pre-arranged trading plan?

Yes. The filing explicitly describes the transaction as a stock options exercise and sale pursuant to a 10b5-1 plan, indicating the sale followed that pre-arranged plan's terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 04:00 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001716268
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Gut Robert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	7552	196725.35	63067485	06/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/10/2026	Stock Options Exercise and Sale pursuant to 10B5-1 Plan	UniQure N.A.			2645	06/10/2026	Cash
Ordinary Shares	02/27/2020	Vested Shares Pursuant to 10b5-1 plan	Uniqure N.V.			3127	02/27/2020	Compensation
Ordinary Shares	02/25/2021	Vested Shares Pursuant to 10b5-1 plan	Uniqure N.V.			1780	02/25/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	shares sold were pursuant to an established 10b51 plan adopted July 2025
Date of Notice	06/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)